Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Retatrutide is investigational and is not currently FDA-approved as a prescription weight-loss medication
These agents mimic GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, and slowing gastric emptying to improve glycemic control, as indicated by reduced HbA1c level, a crucial measure in diabetes care [2, 3]
Qiao G, Lv T, Zhang M, Chen P, Sun Q, Zhang J, et al
This approval was based on a clinical trial that demonstrated Wegovys effectiveness in significantly lowering these risks compared to a placebo
US$ 26.05
US$ 23.08
US$ 22.43
US$ 20.97
US$ 25.69
US$ 27.81
US$ 20.15
US$ 23.24
US$ 29.91
